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SHORT COMMUNICATION
Inhibition by isoproterenol and neostigmine of experimental
carcinogenesis in rat colon by azoxymethane
M. Tatsutal, H. Iishil, H. Yamamural, M. Babal & H. Taniguchi2
Departments of IGastrointestinal Oncology and 2Pathology, The Center for Adult Diseases, Osaka, 3-3, Nakamichi
1-chome, Higashinari-ku, Osaka 537, Japan.
Cell proliferation in the colonic crypt is postulated to be
controlled by the autonomic nervous system (Tutton, 1975;
Tutton & Barkla, 1977, 1980; Kennedy et al., 1983, 1985).
Tutton and Barkla (1977) reported that a beta-adrenergic
agonist inhibited the mitotic rate in colonic carcinomas
induced by dimethylhydrazine (DMH). Tutton (1975) also
reported that cholinoceptor stimulation, either by injection
of carbachol or by inhibition of acetylcholinesterase, resulted
in an increase in the mitotic rate in the crypts of Lieberkiihn
in rat jejunum. These findings suggested that the autonomic
nervous system influences growth of colonic tumours. There-
fore, in the present work, we examined the effects of
prolonged treatment of rats with the beta-adrenergic agonist
isoproterenol, and the acetylcholinesterase inhibitor neostig-
mine from before the time of injection of a carcinogen on
the development of colonic tumours.
A total of 111 young male Wistar rats weighing 80-90g
were randomly divided into 6 groups and treated as follows.
Group 1 (25 rats) received alternate-day subcutaneous injec-
tion of 0.5mgkg- 1 body wt of dl-isoproterenol hydrochlo-
ride (isoproterenol, Sigma, St. Louis, MO) per day as a
suspension in olive oil. From week 3, it was also given 10,
weekly s.c. injections of 7.4mgkg-1 body wt of azoxymeth-
ane (AOM, Sigma) in 0.9% NaCl solution. Group 2 (25 rats)
received alternate-day s.c. injections of0.1 mgkg- 1 body wt of
neostigmine methylsulphate (neostigmine, Sigma) per day in
depot form, and from week 3, AOM for 10 weeks in the
same way as Group 1. Group 3 (25 rats) were first given
only the vehicle, olive oil, and then from week 3, were given
AOM for 10 weeks in the same way as Group 1. Group 4
(12 rats) were given isoproterenol only in the same way as
Group 1 and were not treated with AOM. Group 5 (12 rats)
were given neostigmine only in the same way as Group 2,
and were not treated with AOM. Group 6 (12 rats) were
given neither isoproterenol, neostigmine nor AOM.
The first tumour of the colon was found in week 32, so
animals that survived for more than 32 experimental weeks
were included in effective numbers. All surviving animals
were killed at the end of week 40. The presence of tumour
was verified by microscopy. Labelling indices of the colonic
mucosa in proximal and distal parts of the colon and/or the
colonic tumours were examined in weeks 7 and 40. In week
7, the rats were killed 24h after the last injection of AOM.
The labelling indices of the colonic mucosa and tumours
were measured with kit for immunohistochemical analysis of
bromodeoxyuridine (BrdU) incorporation (Becton Dickin-
son, Mountain View, CA), by the modified method described
by Tada et al. (1985). The results were analyzed by Student's
t-test, the chi-square test or Fisher's exact probability test.
Data are given as mean+s.e. 'Significant' indicates a calcu-
lated P value of less than 0.05.
Table I summarizes the incidences and numbers of colonic
tumours in each group. In Groups 1 and 2, the incidences of
tumours and numbers per rat were significantly lower than
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those in Group 1. Histologically, colonic tumours were
chiefly adenocarcinomas in Groups I and 3. However, the
proportion of adenocarcinomas was significantly lower in
Group 2 than in Group 3. No colonic tumours were found
in Groups 4, 5 and 6.
Table II summarizes data on the labelling indices of
colonic mucosa and colonic tumours in each group in weeks
7 and 40. In Group 1, isoproterenol caused a significant
decrease in labelling index of the colonic tumours, but had
no influence on the labelling indices of colonic mucosa
during or after carcinogen treatment. Administration of
neostigmine of Group 2 decreased significantly the labelling
indices of colonic mucosa during carcinogen treatment but
increased it after carcinogen treatment.
Epithelial proliferation in the colon may be regulated by
the autonomic nervous system. In the present work, we
found that prolonged administration of the beta-adrenergic
agonist isoproterenol from before AOM-treatment resulted
in a significant decrease in the incidence and number of
colonic tumours in week 40. Tutton and Barkla (1977) found
that in rats, a beta-adrenergic agonist inhibited the mitotic
rate in DMH-induced colonic carcinomas. More recently,
Chang (1985) found that isoproterenol treatment soon after
each weekly injection of DMH inhibited the initiation phase
of colonic carcinogenesis. These findings indicate that the
inhibitory effect of the beta-adrenergic agonist on the deve-
lopment of colonic tumours may be related to its effect in
decreasing the proliferation of colonic tumours. However,
our results were somewhat different from those of Kennedy
et al. (1983) showing an inhibitory effect of isoproterenol on
intestinal cell proliferation. This difference in findings may
be attributable to the difference in the methods of the
cytokinetic studies.
Gurkalo and Volfson (1982) examined the effects of
nicotine on the development of gastric cancers induced by
N-methyl-N'-nitro-N-nitrosoguanidine and suggested that
compounds that enhance cholinergic functions inhibit carci-
nogenesis. In the present work, we found that prolonged
administration of an inhibitor of acetylcholinesterase, neos-
tigmine, resulted in a significant decrease in the incidence
and number of colonic tumours in week 40. We also found
that neostigmine significantly decreased the labelling indices
of colonic mucosa during AOM-treatment. This effect of
neostigmine in decreasing the labelling indices during AOM-
treatment may be related to its effect in inhibiting develop-
ment of colonic tumours.
Tutton and Barkla (1976) examined the colonic mucosal
abnormalities in carcinogen-treated rats, and found that a
slight fall in overall crypt cell metaphase rate in the descend-
ing colon of rats treated with DMH. Pozharisski et al. (1982)
found that the proportion of morphologically abnormal
mitoses increased from 4% in normal mucosae to 50-60% in
DMH-treated colon. In the present work, we found that
AOM had a stimulating effect on colonic cell proliferation.
We also found that the effects of neostigmine on cell
proliferation were different during hnd after carcinogen
treatment. In the present work, neostigmine decreased label-
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Table I Body weight and incidence and number of colonic tumours in each group
Body weight Effective No. of rats
Group no. of with colonic No. of colonic
no. Treatment Initial 40 W rats tumours (%) tumours per rat
1. AOM+isoproterenol 85+2 345+ 15 18 10 (55.6)a 0.8+0.2b
2. AOM+neostigmine 89+1 339+10 19 9 (47.4)c 0.7_0.2d
3. AOM+olive oil 84+2 350+ 11 20 18 (90.0) 1.9+0.2
4. Isoproterenol alone 84+1 351+15 7 0 (0.0) 0.0+0.0
5. Neostigmine alone 85 + 3 343+15 7 0 (0.0) 0.0+0.0
6. Olive oil alone 83+2 336+ 19 7 0 (0.0) 0.0+0.0
Significance of difference from value for Group 3; ap<0.05, bp<0.005, cp<0.02, dp<0.001.
Table II Labelling indices of colonic mucosa and colonic adenocarcinomas
Experi- Colonic mucosaa
mental Group Colonicb
week no. Treatment Distal part Proximal part tumours
7 1. AOM+isoproterenol 7.9+0.5 7.7+0.5 -
2. AOM +neostigmine 5.5+0.3c 4.0+0.3d -
3. AOM+olive oil 9.3+0.9 7.6+0.3 -
4. Isoproterenol alone 1.0+0.1 1.0+0.1 -
5. Neostigmine alone 0.9+0.1 1.0+0.1 -
6. Olive oil alone 1.0+0.1 1.0+0.1 -
40 1. AOM+isoproterenol 1.1+0.1 1.2+0.1 19.9+ 1.6c
2. AOM+neostigmine 1.7+0.1d 2.5+0.1d 28.2+1.4
3. AOM+olive oil 0.9+0.1 1.3+0.1 26.7+0.7
4. Isoproterenol alone 0.9+0.1 1.0+0.1 -
5. Neostigmine alone 1.0+0.1 1.3+0.1e
6. Olive oil alone 0.9+0.1 1.0+0.1
aNo. of BrdU-labelled cells per gland; bPercentage of BrdU-labelled cells per 200 cells examined; cDifference from the value for Group 3 significant at P<0.005; dDifference from the value for
Group 3 significant at P<0.001; eDifference from the value for Group 6 significant at P<0.05.
ling indices of the colonic mucosa in week 7 but increased it
in week 40. Tutton (1975) showed that cholinoceptor stimu-
lation resulted in an increase in the mitotic rate in the crypts
of Lieberkuhn in rat jejunum. It is not clear why the effects
of neostigmine were different during and after AOM-
treatment; this point requires further investigation.
In the present work, we found that prolonged administ-
ration of a beta-adrenergic agonist or an acetylcholinesterase
inhibitor from before the time of injection of a carcinogen
significantly inhibited development of colonic tumours.
These findings indicate that tumour growth in the colon is
also controlled by the autonomic nervous system.
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